While SCI affects persons of all ages, much of the published evidence, on-going research and networks focus on SCI in adults. As a result, there is not a lot of available evidence-based research to help determine the best treatments options for children with SCI.
Hosted outside of the United States for the first time, Unite 2 Fight Paralysis' annual Working 2 Walk (W2W) Science and Advocacy Symposium will be in Vancouver on October 19-20.
We are pleased to share an update on the RHI-Hebrew University of Jerusalem BioDesign Partnership that was announced last August. Guided by RHI, the Hebrew University of Jerusalem and RHI-sponsored researcher, Dr. Yaron Blinder, two teams that participated in the one-year BioDesign Program developed solutions for common complications that affect people with SCI.
The Rick Hansen Institute is pleased to announce the appointment of Ben Almond to the RHI Board of Directors. Ben Almond is the Regional Director, Canada at Jacobs a design, engineering, construction and technical services firm that provides innovative end-to-end solutions to their clients. In 2017, Ben was named one of Canada's Top 40 Under 40.